Solventum Corp | SOLV - Current Liabilities


Solventum Corp reported $3.35B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Align Technology USD 1.91B 14.16M Mar/2026
Baxter International USD 3.69B 723M Mar/2026
Becton, Dickinson and Co. USD 8.51B 254M Mar/2026
Cencora USD 59.13B 1.31B Dec/2025
Dexcom USD 2.22B 81.3M Mar/2026
Insulet USD 687.5M 7.4M Mar/2026
Solventum Corp USD 3.35B 210M Mar/2026
West Pharmaceutical Services USD 674M 19.1M Mar/2026
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026